S-5207-119
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sponsored by Shelley Capito (R-WV)
What it does
This bill would formally codify the Rural Communities Opioid Response Program (RCORP) into the Public Health Service Act, directing the Health Resources and Services Administration (HRSA) to maintain the program. It would authorize HRSA to award grants and cooperative agreements to states, tribal organizations, state offices of rural health, and other domestic entities for up to five years each, to fund opioid and substance use disorder prevention, treatment, and recovery services in rural areas. The bill would authorize $165 million per fiscal year from 2027 through 2031, for a total of $825 million over five years.
Who benefits
Rural residents affected by opioid and substance use disorders, who currently have fewer treatment options than urban populations. Indian Tribes and Tribal organizations in rural areas, which are explicitly listed as eligible grantees. State offices of rural health and community health organizations that would receive funding. Healthcare providers in rural areas who would gain resources to expand services. Families of people with substance use disorders in rural communities. Researchers and public health professionals who study rural opioid trends.
Who is hurt
Urban and suburban communities with substance use disorder needs who would not be eligible for this specific funding stream. Competing grant applicants who may be crowded out if HRSA prioritizes certain entity types. Taxpayers who bear the cost of the $825 million authorization. Organizations that provide real property acquisition or improvement services, which are explicitly excluded from using grant funds. States or localities that might prefer block grant flexibility over a targeted federal program with application requirements.
Supporters argue
Supporters argue that rural communities face a disproportionate opioid burden — rural overdose death rates have exceeded urban rates in recent years — while having far fewer treatment providers, with many rural counties lacking a single addiction specialist. They contend that codifying RCORP into statute provides long-term program stability that annual appropriations alone cannot guarantee, and that the five-year grant periods allow grantees to build sustainable, evidence-based delivery models rather than scrambling for short-term funding renewals.
Opponents argue
Opponents argue that authorizing $165 million annually adds to federal spending without evidence that RCORP grants, as currently structured, produce measurable reductions in rural overdose rates — a metric the bill does not require grantees to demonstrate. They contend that the broad eligibility criteria and open-ended "other activities" provision give HRSA wide discretion with limited accountability, and that states would be better served by flexible block grants that allow local officials to direct resources based on their specific community needs rather than federal program requirements.